The Chemours CompanyCCNYSE
Loading
CC Revenue Growth (YoY Quarterly)•-4.59%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-4.59%
-4.2pp
-43.96%
-26.1pp
-309.74%
-379.0pp
-445.33%
-430.6pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.35%
-0.0pp
+0.48%
+0.1pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -1.27% | +0.44% | +3.93% | -0.40% | -4.59% |
| Gross Profit Growth | +7.06% | -16.90% | -9.74% | -17.83% | -43.96% |
| EBITDA Growth | -9.41% | -24.51% | -25.49% | +69.23% | -309.74% |
| Operating Income Growth | -29.91% | -30.97% | -44.62% | -14.75% | -445.33% |
| Net Income Growth | +0.00% | -107.41% | -735.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | -107.63% | -640.43% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | -107.85% | -640.43% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.83% | +0.59% | +0.55% | +0.36% | +0.35% |
| Weighted Average Shares Diluted Growth | +0.83% | +0.24% | +0.08% | +0.36% | +0.48% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -71.37% | +0.00% | +0.00% | +5.04% | -0.72% |
| Free Cash Flow Growth | -91.64% | +0.00% | +0.00% | +66.67% | +217.24% |
| Receivables Growth | +26.23% | +8.33% | +7.03% | -0.42% | -11.82% |
| Inventory Growth | +8.88% | +11.43% | +13.89% | +7.58% | +6.59% |
| Asset Growth | -8.92% | -7.32% | +3.30% | +1.43% | -1.77% |
| Book Value per Share Growth | -18.72% | -23.46% | -67.40% | -54.81% | -58.75% |
| Debt Growth | +1.30% | +2.84% | +4.04% | +2.91% | +5.28% |
| R&D Expense Growth | +73.33% | -3.57% | +7.69% | -10.34% | +3.85% |
| SG&A Expenses Growth | +0.00% | -11.51% | +0.00% | -100.00% | +300.00% |
1 / 4